bpc 157 dosing protocols research bpc-157 clinical trials dosage BPC-157 (Common Protocols), πΉ Oral / Subcutaneous, β’ 500 mcg daily, β’ Duration: 6 weeks, πΉ Intramuscular / Peritendinous, β’ 1 mg daily, β’ Duration: 6 weeks, β οΈ Note:, Not approved by FDA or how many mg of bpc
Description
It is particularly well-suited for patients over 40 where visceral fat accumulation and age-related GH decline are occurring in parallel
PubMed, Zhou, Dongchen, et al
It has never received FDA approval for human use, and standard drug screens generally do not include assays for peptides like BPC-157
Joint discomfort, gut issues, and slow recovery from exercise are common barriers that can stall progress
